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Postmortem studies have described that olfactory loss observed in normal aging is 
associated with Alzheimer’s type brain degeneration. We hypothesized that distinct 
measures of gray and white matter integrity evaluated through magnetic resonance 
imaging (MRI) techniques could detect degenerative changes associated with age-
related olfactory dysfunction. High-resolution T1-weighted images and diffusion-tensor 
images (DTI) of 30 clinically healthy subjects aged 51 to 77 were acquired with a 3-
Tesla MRI scanner. Odor identification performance was assessed by means of the 
University of Pennsylvania Smell Identification Test (UPSIT). UPSIT scores correlated 
with right amygdalar volume and bilateral perirhinal and entorhinal cortices gray matter 
volume. Olfactory performance also correlated with postcentral gyrus cortical thickness 
and with fractional anisotropy and mean diffusivity levels in the splenium of the corpus 
callosum and the superior longitudinal fasciculi. Our results suggest that age-related 
olfactory loss is accompanied by diffuse degenerative changes that might correspond 
to the preclinical stages of neurodegenerative processes. 
 







































































There is a large body of evidence linking olfactory loss and neurodegenerative 
processes. Olfactory impairments are strongly associated with Parkinson’s (PD) and 
Alzheimer’s (AD) diseases [1, 2], and have been investigated in animal models of AD 
[3].  
In normal aging, the association between olfactory impairment and brain 
degeneration has been reported in a longitudinal clinicopathological study that included 
a large cohort of 471 elderly subjects (Rush Memory and Aging Project). During a 
mean follow-up of 2.2 years, autopsies were obtained from 122 of 166 subjects who 
died, revealing that scores in odor identification correlated with neuropathological 
changes usually associated with AD: density of neurofibrillary tangles in the entorhinal 
cortex and in the CA1 subfield of the hippocampus and the subiculum [4]. 
 In a 5-year follow-up study including subjects from the same cohort, initial smell 
identification test scores were found to be associated with the risk of developing mild 
cognitive impairment (MCI). Moreover, in 34 subjects with olfactory dysfunction who 
died without cognitive deficits, autopsy showed greater burden of AD pathology [5].  
The relationship between olfactory impairment and progressive cognitive 
decline was also seen in an epidemiological study involving 1,920 participants with a 
mean age of 66.9 years. In this study, authors reported an association between 
olfactory impairment and the incidence of MCI 5 years later with an odds-ratio of 6.62 
[6].  
Magnetic resonance imaging (MRI) is an invaluable tool for the study of “in vivo” 
brain correlates of olfactory dysfunctions. In PD, olfactory impairment has been found 





































































(DTI) [7]. On the other hand, voxel-based morphometry (VBM) studies have evidenced 
that subjects with hyposmia and anosmia of different etiology show gray and white 
matter reductions in central regions involved in the olfactory system [8, 9].  
The purpose of the current study was to investigate the cerebral correlates of 
impairments in odor identification in a sample of clinically healthy subjects and to 
correlate the performance in odor identification with measures of MRI cerebral 
degeneration such as cortical thickness, gray matter volumes and measures of white 
matter integrity. We hypothesized that olfactory dysfunctions in older persons could be 
associated with brain olfactory regions but also with other brain regions sensitive to the 




The sample included 30 clinically healthy subjects (12 males; mean age: 66.0 + 
7.4 years, range, 51-77 years; mean years of education: 11.1 + 4.2). All were right 
handed. All the participants were volunteers recruited from the Institut Català de 
l'Envelliment in Barcelona.  
General exclusion criteria were: uncorrected visual or auditory deficits, drug 
abuse, and history of past or current psychiatric or neurologic disorder. Specific 
exclusion criteria for the olfaction test were: history of nasal bone fracture, diagnosis of 
rhinitis or nasal polyps, and upper respiratory tract infections in the 2 weeks prior to or 
at the moment of evaluation. Imaging exclusion criteria included any abnormality 
except mild white matter hyperintensities All selected participants completed a 
screening interview to check relevant medical information. One subject was currently a 



































































All subjects had normal general cognitive performance according to the Mini-
Mental State Examination (scores ≥26) and normal global IQ scores (higher than 85) 
estimated by the Vocabulary subtest of the Wechsler Adult Intelligence Scale-III [12]. 
All participants underwent a comprehensive neuropsychological assessment. 
The study was approved by the ethics committee of the University of Barcelona. 
All enrolled subjects signed an informed consent form before taking part in the study. 
Olfactory assessment 
Odor identification was assessed using the University of Pennsylvania Smell 
Identification Test (UPSIT) [13]. The UPSIT is a standardized forced-choice test 
comprised of four booklets containing 10 odorants apiece, 1 odorant per page. The 
stimuli are embedded in “scratch and sniff” microcapsules fixed and positioned on 
strips at the bottom of each page. A multiple-choice question with four response 
alternatives for each item is located above each odorant strip. Scores are calculated as 
the number of items correctly identified. Respondents can be placed into percentiles 
based on gender- and age-standardized norms for the number of correctly identified 
odorants. The UPSITs are packaged in envelopes and come with easy-to-follow 
instructions. Following normative data presented in the UPSIT manual, scores greater 
than 33 were considered to reflect normosmia and scores lower or equal to 18 were 
classified as anosmia. Scores between 19 and 32 reflected microsmia (from 19 to 25: 





































































We selected a neuropsychological battery including tests described as sensitive 
to aging effects and which have been found to be altered in the preclinical stages of 
Alzheimer’s disease. The battery comprised tests measuring episodic memory (Rey 
Auditory Verbal Learning Test (RAVLT)), visuospatial and visuoperceptual functions 
(Benton’s Judgment of Line Orientation and Facial recognition) and executive functions 
(Trail Making Test, Stroop Color-Word Test and 1 minute of phonetic (letters beginning 
with the letter P) and semantic (animals) fluencies). The characteristics of all tests are 
described in Lezak et al. (2004). Neuropsychological test results were analyzed using 
PASW-18 (Chicago, IL, http://www-01.ibm.com/software/analytics/spss/). Group 
differences in neuropsychological performance were tested using 3-level (normosmia, 
mild microsmia, moderate microsmia) one-way ANOVAs. 
 Image acquisition and analysis 
Magnetic resonance images were acquired with a 3T scanner (MAGNETOM 
Trio, Siemens, Germany). High-resolution 3-dimensional T1-weighted images were 
acquired in the sagittal plane (TR 2300 ms, TE 2.98 ms, TI 900 ms; 256 x 256 matrix, 1 
mm isotropic voxel). Sagittal diffusion tensor images were obtained using a single-shot 
EPI sequence (TR 5533 ms, TE 88 ms), with diffusion-encoding in 30 directions at b=0 
and 1000 s/mm2. 
Structural data was analyzed with FSL-VBM [15], a voxel-based morphometry-
style analysis carried out with FSL tools (http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FSL.) First, 
nonbrain tissue from structural images was extracted. After segmentation, GM images 
were aligned to MNI152 standard space using affine registration. The resulting images 
were averaged to create a study-specific template, to which the native GM images 
were then non-linearly re-registered. The registered partial volume images were then 





































































the warp field. The modulated segmented images were then smoothed with an 
isotropic Gaussian kernel with a sigma of 3 mm.  
Voxelwise statistical analysis of fractional anisotropy (FA) and mean diffusivity 
(MD) data was carried out using TBSS (Tract-Based Spatial Statistics, [[16]]), part of 
FSL. First, FA and MD images were created by fitting a tensor model to the raw 
diffusion data using FDT, and then brain-extracted using BET [17]. All subjects' FA and 
MD data were then aligned into a common space using the nonlinear registration tool 
FNIRT (http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FNIRT) which uses a b-spline representation 
of the registration warp field [18]. Next, the mean FA and MD image were created and 
thinned to create a mean FA and MD skeleton which represents the centers of all tracts 
common to the group. Each subject's aligned FA and MD data were then projected 
onto this skeleton and the resulting data fed into voxelwise cross-subject statistics. 
Structures used as regions of interest (ROIs) for GM analysis were chosen 
based on literature about the olfactory system. The included structures were the 
amygdala, hippocampus, parahippocampal gyrus (encompassing entorhinal and 
perirhinal areas), olfactory portion of the orbitofrontal cortex, gyrus rectus and insula 
bilaterally. The Automated Anatomical Labelling (AAL) atlas [19] was used to create the 
corresponding masks.  
Finally, voxelwise general linear model was applied using permutation-based 
non-parametric testing (5000 permutations) for FA, MD and GM analyses, correcting 
for multiple comparisons across space using familywise error correction (FWE). 
The estimation of cortical thickness was performed using the automated 
FreeSurfer stream (version 5.1; available at: http://surfer.nmr.harvard.edu). The 
procedures carried out by FreeSurfer software include removal of non-brain data, 
intensity normalization [20], tessellation of the gray matter/white matter boundary, 
automated topology correction [21, 22] and accurate surface deformation to identify 
tissue borders [23, 24, 25]). Cortical thickness is then calculated as the distance 



































































mantle [24]. Results for each subject were visually inspected to ensure accuracy of 
registration, skull stripping, segmentation, and cortical surface reconstruction. 
The relationship between cortical thickness and UPSIT scores was assessed 
using a vertex-by-vertex general lineal model. Maps were smoothed using a circularly 
symmetric Gaussian kernel across the surface with a full width at half maximum 
(FWHM) of 15 mm. Z Monte Carlo simulations with 10,000 iterations were applied to 
CTh maps to provide cluster-wise correction for multiple comparisons, and results were 
thresholded at a corrected p value of 0.05 (Z = 1.3). 
The automated procedure for volumetric measures of brain structures 
implemented in FreeSurfer was used to obtain the volumes of subcortical structures. 
Partial correlation between subcortical regions of interest (bilateral hippocampus and 
amygdala) and UPSIT scores, controlling for intracranial volume, were calculated using 
PASW-18 (Chicago, IL, http://www-01.ibm.com/software/analytics/spss/). 
RESULTS 
UPSIT scores ranged from 26 to 37 (mean 31.27, SD 2.95). Seven subjects 
(23.3%) were classified as normosmics; 15 (50%) had mild microsmia, 8 (26.7%) had 
moderate microsmia and none had severe microsmia or anosmia. There were no 
significant differences in these groups’ neuropsychological test results (Table 1). 
There were no significant correlations between age and UPSIT scores (r=-0.124 
p=0.513). Additionally, UPSIT scores did not differ between males and females (t=0.09, 
p=0.920); thus, age and gender were not entered as covariates in the MRI models. 
UPSIT scores correlated positively with cortical thickness in the right postcentral 
gyrus, indicating that olfactory dysfunction is associated with cortical thinning in this 
region (z=3.128; p<0.05, Montecarlo correction; cluster size: 1378.59 mm2; 



































































Whole brain VBM analyses did not show any significant correlations at the 
corrected level. On the other hand, region-of-interest VBM analysis revealed a 
significant positive correlation between UPSIT scores and bilateral parahippocampal 
(entorhinal and perirhinal cortices) gray matter volumes. Left-side cluster: r=0.62; 
p=.017, FWE-correction; cluster volume: 776 mm3; x,y,z MNI coordinates of the 
maximum: -26, -10, -34. Right-side cluster: r=0.63; p=.017, FWE-correction; cluster 
volume: 1296 mm3; x,y,z MNI coordinates of the maximum: 20, -12, -28 ( Figure 2). 
Moreover, UPSIT scores also correlated with the volume of the right amydgala 
corrected by intracranial volume (r=0.413, p=0.026) 
Regarding DTI results, UPSIT scores correlated positively with FA and 
negatively with MD values in bilateral parietal as well as right temporal and right frontal 
white matter regions, corresponding to the topography of the superior longitudinal 
fasciculi, the inferior occipito-frontal fasciculus, anterior thalamic radiation, and the 
corpus callosum (Figure 3). 
DISCUSSION 
In this study, we found that olfactory loss in normal subjects correlated with 
several brain measures of gray and white matter integrity. We observed correlations of 
UPSIT scores with several structures involved in olfactory function such as the 
perirhinal and entorhinal cortices and the amygdala. Bitter et al. [8], using a VBM 
approach, described that subjects with anosmia of different etiology had gray matter 
reductions in primary as well as secondary olfactory regions. In the same line of our 
correlational data, they found gray matter volume reductions in anosmic patients in the 
parahippocampal gryrus, but they also found decrements in associative regions such 
as the medial prefrontal cortex. The widespread gray matter reductions they reported 





































































presented anosmia) and that a more liberal threshold of significance (p<0.01, not 
corrected for multiple comparisons) was used. In their study, at the corrected level, only 
the medial/anterior cingulate region remained significant. The same group of research 
in a sample with less severe olfactory loss (hyposmic subjects) found gray matter 
reductions in the insular cortex, anterior cingulate cortex, orbitofrontal cortex, 
cerebellum, fusiform gyrus, precuneus, middle temporal gyrus and perirhinal cortex. 
However, the results were also obtained at an uncorrected level of significance. The 
authors interpreted their findings as secondary to the reduced olfactory input, because 
a subsample of subjects with hyposmia of peripheral origin of the olfactory impairment 
has similar gray matter reductions. The samples of both studies included young and old 
people thus aging effects could not be isolated. 
In addition to the classical structures of the olfactory system, we also found 
correlations of UPSIT scores with cortical thickness in the neocortex. Specifically, we 
found that right postcentral gyrus thinning is related with poor performance in olfaction 
or in other words that thicker cortex in this region is associated with better performance 
in odor identification. Curiously, this result is in agreement with the data obtained by 
Frasnelli et al (2010) in a sample of 46 healthy young university students. These 
authors found that a composite olfactory score positively correlated with the 
performance and cortical thickness in the right dorsal postcentral gyrus. Thus, it is 
possible that such relationship in our sample reflected individual differences in odor 
perception acquired during young ages rather than aging effects.  
DTI analyses have provided evidence of the association between degenerative 
brain changes and olfactory dysfunction in our sample. At the corrected level, we found 
that UPSIT scores positively correlated with FA scores and negatively with MD scores 
mainly involving the the corpus callosum and the superior longitudinal fasciculi. These 
results indicate that the loss of integrity of the cerebral fibers is related to loss of 





































































to the olfactory circuitry. In our opinion, this correlation reflects a common cause of 
degeneration for the olfactory system and other brain structures. Aging per se doesn’t 
seem to be responsible for olfactory loss in our sample; we haven’t observed any 
correlations between UPSIT scores and age. It is possible that a subsample of our 
subjects might instead be in the preclinical stage of a degenerative illness. This 
subsample could have both degeneration in limbic structures directly explaining the 
olfactory dysfunctions and subtle changes in the neocortical circuitry reflecting a more 
generalized degeneration.  
There is wide evidence on the olfactory loss as a preclinical or prodromal sign 
of brain degeneration. Carriers of the CAG repeat expansion who are not yet 
diagnosed with Huntington’s disease [26] have decreased UPSIT scores between 9 
and 15 years before the estimated onset of the disease. Hyposmia is listed among the 
nonmotor symptom of PD (alongside constipation, daytime sleepiness, and rapid eye 
movement sleep behavior disorders and affective symptoms), and is also present in 
undiagnosed individuals at risk for PD (first-degree relatives of PD patients) [27], being 
considered a nonmotor feature which may precede by years the onset of motor disease 
[28-30]. Moreover, olfaction is impaired in PD patients with leucine-rich repeat kinase 
(LRRK2) G2019S mutations, and also in a subset of LRRK2 carriers without PD [31]. It 
has also been found that severe olfactory dysfunction is a prodromal symptom of 
dementia [32]. 
Hyposmia is seen in early stages of PD and in subjects with MCI [33, 34]. 
Higher density of entorhinal cortex and hippocampal neurofibrillary tangles correlates 
with greater deficits in odor identification, suggesting a role for hippocampal 
dysfunction in Alzheimer’s disease hyposmia [4]. Olfactory dysfunctions are predictive 
of cognitive decline in the elderly and interact with the ApoEε4 allele [35-37]. 
Longitudinal MRI studies are needed to clarify the clinical significance of the specific 



































































In summary, we found that olfactory loss in normal aged people is associated 
with impairment in some olfactory regions such as the amygdala, entorhinal and 
perirhinal cortex, but also with other cerebral regions not related with this function. The 
fact that individuals with olfactory loss had several signs of brain degeneration is in 
agreement with the idea that olfactory loss could be a preclinical marker of 
degenerative illness. 
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MMSE 29.3 ± 1.1 29.8 ± 0.4 29.5 ± 0.5 1.565 / 0.227 
Memory 
RAVLT learning 44.7 ± 5.2 44.5 ± 6.0 43.6 ± 4.3 0.096 / 0.909 
RAVLT delayed recall 8.4 ± 2.1 8.9 ± 2.0 9.6 ± 2.1 0.697 / 0.507 
RAVLT recognition 13.3 ± 2.1 13.7 ± 1.4 14.0 ± 1.1 0.423 / 0.659 
Executive Functions 
TMT A, seconds 35.3 ± 14.6 39.3 ± 13.2 41.6 ± 13.2 0.419 / 0.662 
TMT B, seconds 92.3 ± 51.7 90.0 ± 33.3 107.3 ± 26.0 0.605 / 0.553 
SCWT, words 101.7 ± 20.8 96.3 ± 16.0 100.8 ± 7.3 0.386 / 0.683 
SCWT, color 63.6 ± 11.5 59.6 ± 17.9 62.5 ± 12.0 0.195 / 0.824 
SCWT, interference 6.6 ± 6.3 2.9 ± 7.9 -2.3 ± 7.4 0.996 / 0.382 
Digits - forward span 5.8 ± 1.6 5.5 ± 1.5 5.5 ± 1.2 0.116 / 0.891 
Digits - backward span 4.5 ± 1.6 4.2 ± 1.1 3.4 ± 0.9 1.886 / 0.172 
Phonemic verbal fluency 16.0 ± 4.7 16.7 ± 5.9 17.3 ± 5.5 0.095 / 0.910 
Semantic verbal fluency 20.0 ± 2.9 20.7 ± 4.6 23.3 ± 8.2 0.766 / 0.475 
Visuospatial and visuoperceptual 
JLO 24.4 ± 6.7 23.0 ± 4.4 22.9 ± 2.9 0.263 / 0.771 
Facial recognition 44.6 ± 3.6 46.7 ± 3.4 43.5 ± 3.7 2.405 / 0.109 
Table 1. Neuropsychological assessment results in mean ± standard deviation.F/p: F-
test and significance level of one-way ANOVAs comparing the 3 groups. MMSE: Mini-
Mental State Examination, RAVLT: Rey Auditory Verbal Learning Test, TMT: Trail 
Making test, SCWT: Stroop Color-Word Test, JLO: Benton’s Judgment of Line 




































































Figure 1. Area of signiticant (p<0.05, Monte Carlo-corrected) positive correlation 
between UPSIT scores and right postcental gyrus cortical thickness. 
Figure 2. VBM results: areas of significant (p<0.05, FWE-corrected) positive correlation 
between UPSIT scores and perirrhinal and enthorrinal cortex GM volume. 
Figure 3. DTI results. Areas of significant (p<0.05, FWE-corrected) correlations 
between UPSIT and FA (red) and MD (blue) values. Plots represent the positive (FA) 
and negative (MD) correlations. 
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